The first FDA-cleared device that supports concurrent reading, allowing for faster reading with proven, superior, automatic nodule detection.
Our five FDA-cleared applications are designed to improve reading efficiency and accuracy across the hospital enterprise without additional equipment, procedures or radiation dose.
Riverain’s deep learning AI technology is FDA cleared, field tested, and clinically proven to provide real results in radiology.
Riverain Technologies advanced AI imaging software is in use by leading healthcare organizations around the world.
Peer reviews, reference accounts, and independent studies confirm that ClearRead technology is positively impacting the field of radiology.
Managing your lung program can seem daunting, whether you’re getting going, growing, or managing workflow. We’ve curated resources for you.
Chest X-rays help identify many abnormalities, but interpretation is often difficult due to obstructing bone, patient positioning, and image quality. Radiologists are often at the mercy of what only their eyes can see. Riverain’s ClearRead Xray with Clear Visual IntelligenceTM uses our unique suppression technology to provide an unimpaired view of the chest to reveal the actionable data to correctly and quickly detect cardio-thoracic diseases for a brighter future and better patient outcomes.
The ClearRead Xray platform is comprised of five FDA-cleared applications designed to improve reading efficiency and accuracy across the hospital enterprise without requiring additional imaging equipment. The solutions optimize the diagnostic value of all portable and upright images.
ClearRead Xray Bone Suppress increases the visibility of soft tissue in standard chest X-rays by suppressing the bone on the digital image without the need for two exposures. The bone-suppressed image helps radiologists to detect 1 out of 6 previously missed nodules.1 This enterprise-wide solution uses existing digital XR equipment, providing a soft tissue image for digital chest X-rays.
Using FDA cleared, clinically approved AI technology, ClearRead Xray’s Bone Suppress actually removes bone structure from existing XRs to give radiologists a more accurate view of the lungs. No additional radiation dose or changes to existing imaging protocols are required. Drag the arrow in the center of the image left or right to see the ClearRead difference.
ClearRead Xray Detect offers improved detection of 9-30mm nodules, detection of 1 in 2 previously missed lung nodules, and it allows radiologists to detect lung cancer up to 18 months sooner.3 The newest FDA approved version offers superior marking capabilities with an improved 75% reduction in false positives and improvement in sensitivity.
ClearRead Xray Detect leverages Bone Suppression and automatically detects nodules. Move the arrow in the center of the image left or right to see the ClearRead difference.
With ClearRead Xray Enhance, radiologists can reduce portable reading time by approximately 19% without compromising accuracy or confidence.4 ClearRead Xray Enhance identifies and highlights lines and tubes on portable chest XR images while maintaining excellent image quality. Since diagnostic quality is preserved, radiologists can minimize imaging adjustments and decrease reading time.
To demonstrate the dramatic difference in image quality, use the arrows above the images to scroll through the Current and Enhanced views of the following galleries.
Early detection of pneumothorax is vital to this life-threatening emergency. However, pneumothorax can be easily disguised due to its curved contour, patient positioning, and low contrast. ClearRead Xray Pneumothorax provides a triage notification in cases with suspected pneumothorax. ClearRead works on all adult upright and portable chest X-ray devices.
In an independent third party clinical trial with over 1100 studies, the sensitivity and specificity of ClearRead Xray Pneumothorax performed robustly, even in the presence of 10 common co-morbidities and on six different manufacturers’ devices.
Use the arrows to view the pneumothorax cases with notifications from ClearRead Xray Pneumothorax. Red arrow indicates location of pneumothorax and is not provided as part of the machine output.
ClearRead Xray Compare aided radiologists to detect 1 in 10 previously missed emerging nodules.5 It provides a clear illustration of density changes between current and prior chest XR images. This historical comparison enables radiologists to discover typically unseen diagnostic potential, allowing earlier disease detection and improved patient outcomes without an additional radiation dose.
For a demonstration of the effectiveness the Compare technology, scroll through the Current/Prior/Difference states of the following images, using the arrows above the galleries for navigation.
Our acquisition normalization technology supports rapid installation of software based on elimination of the requirement to tune to specific scanners.
Installation and configuration of our software typically take as little as four hours. The simplicity of the ClearRead installation on site is based on Riverain’s image normalization technology that eliminates the need for tuning to specific manufacturers or imaging protocols. Using the existing PACS review station for image interpretation also simplifies deployment.
Our acquisition normalization technology supports rapid installation of software based on elimination of the requirement to tune to specific scanners.
Installation and configuration of our software typically take as little as four hours. The simplicity of the ClearRead installation on site is based on Riverain’s image normalization technology that eliminates the need for tuning to specific manufacturers or imaging protocols. Using the existing PACS review station for image interpretation also simplifies deployment.
Seamless PACS integration allows readers to view ClearRead as an additional series in the patient study without the need for a separate application viewer to read studies quickly and intuitively for speed and accuracy.
The seamless PACS integration makes viewing the ClearRead Xray images easy. ClearRead Xray Enhance image can be viewed at the portable modality for real-time feedback.
Seamless PACS integration allows readers to view ClearRead as an additional series in the patient study without the need for a separate application viewer to read studies quickly and intuitively for speed and accuracy.
The seamless PACS integration makes viewing the ClearRead Xray images easy. ClearRead Xray Enhance image can be viewed at the portable modality for real-time feedback.
ClearRead technology implements the latest artificial intelligence and deep learning technologies for optimized content, workflow, and results.
ClearRead Xray technology has surpassed the state-of-the-art by a significant margin based on a combination of frameworks, modeling, and computational ingenuity. While achieving high reliability and significant performance usually depends on substantial amounts of processing, our system can run on commodity hardware, without the need for special computer cards or large memory systems.
ClearRead technology implements the latest artificial intelligence and deep learning technologies for optimized content, workflow, and results.
ClearRead Xray technology has surpassed the state-of-the-art by a significant margin based on a combination of frameworks, modeling, and computational ingenuity. While achieving high reliability and significant performance usually depends on substantial amounts of processing, our system can run on commodity hardware, without the need for special computer cards or large memory systems.
Our advanced AI imaging software is used by leading international healthcare organizations and is continually evaluated for its effectiveness.
Ultimately, Riverain understands that the main concern of clinicians when adopting new software is knowing that it is properly verified and validated. Peer reviewed articles; third-party studies and reference accounts are essential to the integrity of our ClearRead AI technology. Our success is supported by ample clinical evidence.
Our advanced AI imaging software is used by leading international healthcare organizations and is continually evaluated for its effectiveness.
Ultimately, Riverain understands that the main concern of clinicians when adopting new software is knowing that it is properly verified and validated. Peer reviewed articles; third-party studies and reference accounts are essential to the integrity of our ClearRead AI technology. Our success is supported by ample clinical evidence.
Our technology is revolutionizing radiology. We’d love to work with you to help create better outcomes for patients everywhere.
